Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000093751-19-000171
Filing Date
2019-02-13
Accepted
2019-02-13 16:34:01
Documents
1

Document Format Files

Seq Description Document Type Size
1 SANGAMO THERAPEUTICS, INC. SangamoTherapeuticsInc.txt SC 13G 6835
  Complete submission text file 0000093751-19-000171.txt   8797
Mailing Address ONE LINCOLN STREET BOSTON MA 02111
Business Address ONE LINCOLN STREET BOSTON MA 02111 617 786-3000
STATE STREET CORP (Filed by) CIK: 0000093751 (see all company filings)

EIN.: 042456637 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G
SIC: 6022 State Commercial Banks

Mailing Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804
Business Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804 5109706000
SANGAMO THERAPEUTICS, INC (Subject) CIK: 0001001233 (see all company filings)

EIN.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-59049 | Film No.: 19597831
SIC: 2836 Biological Products, (No Diagnostic Substances)